After Alzheimer's disease, Parkinson's disease (PD) is the second most prevalent and
incidental neurodegenerative disorder, affecting more than 2% of the population older than …

Parkinson's disease (PD) is the most common neurodegenerative movement disorder in the
elderly. As the pathogenesis of PD is still not fully understood, medications with the capacity …

Since the first formal description of Parkinson disease (PD) two centuries ago, our
understanding of this common neurodegenerative disorder has expanded at all levels of …

Parkinson's disease is the second most common neurodegenerative disorder. Despite fairly
typical clinical and pathologic features, the etiology remains unknown. Many cellular …

Parkinson's disease (PD) is a progressive neurodegenerative disease characterized
typically by motor features of tremor, rigidity and bradykinesia due to depletion of …

Parkinson's disease (PD) is a chronic and progressive neurodegenerative disease with
complex causes. Through scientific investigation of the gene products identified to be linked …

Sporadic or idiopathic Parkinson's disease (PD) is an age-related neurodegenerative
disorder of unknown origin that ranks only second behind Alzheimer's disease (AD) in …

Gradual degeneration and loss of dopaminergic neurons in the substantia nigra, pars
compacta and subsequent reduction of dopamine levels in striatum are associated with …

Parkinson's disease (PD) is a complex multifactor disease marked by extensive
neuropathology in the brain with selective yet prominent and progressive loss of midbrain …

The Parkinson's disease research field is a rapidly moving one, as many of the relevant
processes underlying PD neurodegeneration are being deciphered, enabling novel …